Recent updates in human leukocyte antigen B27-associated uveitis

Area of Science:

• Ophthalmology
• Rheumatology
• Immunology

Background:

• Anterior uveitis (AU), particularly acute anterior uveitis (AAU), is often the initial sign of human leukocyte antigen (HLA) B27-associated spondyloarthropathies (SpA).
• Systemic manifestations of HLA B27-related disease, including ankylosing spondylitis and inflammatory bowel disease, present diagnostic and therapeutic challenges.
• Ophthalmologists play a crucial role in the early identification and etiological evaluation of HLA B27-related conditions.

Purpose of the Study:

• To explore the evolving understanding of the human leukocyte antigen (HLA) B27 molecule.
• To discuss recent advancements in the cellular, molecular, biochemical, and clinical aspects of HLA B27-related disease.
• To highlight the importance of multidisciplinary collaboration in managing this multisystem condition.

Main Methods:

• Review of current literature on HLA B27-related uveitis and spondyloarthropathies.
• Discussion of recent immunological and molecular medicine findings.
• Emphasis on clinical presentation and diagnostic approaches.

Main Results:

• Significant progress in understanding the pathogenesis and clinical spectrum of HLA B27-related uveitis and SpA.
• Emerging insights into the roles of gut microbiome, autoinflammation, and innate immunity.
• Development of targeted biologic and synthetic disease-modifying therapies based on improved knowledge of cytokine networks.

Conclusions:

• Optimal management of HLA B27-associated disease requires a multidisciplinary approach involving ophthalmologists, rheumatologists, gastroenterologists, and internists.
• Continued research into the complex mechanisms of HLA B27 is essential for advancing diagnostics and therapeutics.
• Early recognition and intervention by ophthalmologists are critical for improving patient outcomes.